ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GenScript Receives EUA for Use of cPass SARS-CoV-2 Neutralization Antibody Test
February 24, 2021GenScript has received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma ... -
GenScript Files for EUA of Rapid SARS-CoV-2 Neutralization Antibody Detection Kit
June 15, 2020GenScript Biotech announced the company has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to market its cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit.
Pharma Sources Insight January 2025
